Monitoring the responses to hepatitis B and C epidemics in the EU/EEA Member States, 2019
This report provides the first collation of data relating to the monitoring of the progress towards the elimination of hepatitis B and C for EU/EEA countries. This collated information represents an important step towards understanding the priority areas for action and gaps in the national responses to the hepatitis B and C epidemics. The data also provide an important baseline to help map progress towards the WHO elimination targets and ultimately achieve the 2030 sustainable development goals.
Systematic scoping review on social media monitoring methods and interventions relating to vaccine hesitancy
Understanding vaccine hesitancy and social media: which social media platforms do users preferably choose as source of information on vaccination and how does that influence their perceptions of vaccination? A systematic scoping review by ECDC and the Vaccine Confidence Project summarises knowledge and research on social media and vaccination.
European external quality assessment programme for influenza virus 2018
Influenza epidemics occur every winter with high impact on disease burden, hospitalisations and excess mortality in countries in the WHO European Region. To understand the characteristics of circulating influenza viruses during seasonal epidemics, virological influenza surveillance is performed and detected viruses are further characterised at national influenza centres (NICs) that are part of the wider network of the WHO Global Influenza Surveillance and Response System (GISRS). External quality assessments (EQAs) are important instruments in assessing the quality of the generated data that are reported nationally and internationally through The European Surveillance System (TESSy).
External quality assessment for the detection of Bordetella pertussis by PCR, 2018
This report presents the results of the second European Pertussis Laboratory Surveillance Network (EUPert-LabNet) EQA scheme for Bordetella pertussis PCR funded by ECDC on behalf of EUPert-LabNet. The EQA study was conducted between February and March 2018.
Seasonal influenza vaccination and antiviral use in EU/EEA Member States
Overview of vaccine recommendations for 2017–2018 and vaccination coverage rates for 2015–2016 and 2016–2017 influenza seasons.
Hepatitis B and C testing strategies in healthcare and community settings in the EU/EEA
The scope of this project was to provide an overview of different effective testing strategies for hepatitis B and C and their outcomes in the EU/EEA, covering all relevant population groups and settings.
Retrospective surveillance and enhanced case-finding of congenital rubella syndrome cases
The generic protocol presented in this document was developed for ECDC by fellows of the EPIET programme to provide EU/EEA Member States with an adaptable tool to estimate the incidence of congenital rubella syndrome (CRS) cases in their countries.
Review of reviews and guidelines on target groups, diagnosis, treatment and programmatic issues for implementation of latent tuberculosis management
This report is part of a series of technical documents describing the collection, synthesis and appraisal of the available information on specific measures for the prevention, identification and treatment of LTBI, analysed from the perspective of national TB-control programmes.
Generic protocol on enhanced surveillance for invasive pneumococcal disease at the EU/EEA level
The current generic protocol proposes a uniform approach for active invasive pneumococcal disease (IPD) surveillance in children and enhanced surveillance in other age groups.
Hepatitis B and C epidemiology in selected population groups in the EU/EEA
The findings presented in this report will be part of the process of developing a European guidance for HBV and HCV testing and may provide support EU/EEA countries in the development of national guidelines and in the design and scale-up of testing interventions.